Stock listing
NASDAQ:BRKR Bruker Corporation Stock
Home listing (NASDAQ) of Bruker Corporation
Follow Bruker Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:BRKR
$56.46 USD -6.80 (-10.7%)
Close on Nov 20, 2026
- Day range
- $56.13 – $61.10 USDNov 20, 2026
- Volume
- 2.25M sharesNov 20, 2026
- Market cap
- $8.62B USDAt the close on Nov 20, 2026 · price × 152.7M shares outstanding
- 52-week range
- $32.37 – $68.98 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $138.5M USDMedian day 2.17M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BRKR · Home | $56.46 USD | -6.80 (-10.7%) | 2,250,882 | $60.65 | $61.10 | $56.13 | $63.26 | Close on Nov 20, 2026 |
| Frankfurt:BKD | €55.68 EUR | -2.64 (-4.5%) | — | €55.59 | €55.68 | €55.59 | €58.32 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BRKR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $56.46 | -6.80 | -10.7% | $60.65 | $61.10 | $56.13 | 2,250,882 | |
| $63.26 | +1.90 | +3.1% | $61.09 | $64.61 | $61.01 | 1,726,086 | |
| $61.36 | +0.74 | +1.2% | $60.38 | $62.22 | $60.03 | 1,875,188 | |
| $60.62 | -0.97 | -1.6% | $60.52 | $61.81 | $59.50 | 2,645,306 | |
| $61.59 | +1.26 | +2.1% | $60.36 | $61.94 | $59.13 | 2,021,022 | |
| $60.33 | -2.08 | -3.3% | $60.22 | $61.40 | $58.68 | 1,510,997 | |
| $62.41 | +0.17 | +0.3% | $62.90 | $64.28 | $61.96 | 2,467,724 | |
| $62.24 | -4.30 | -6.5% | $66.51 | $66.51 | $62.13 | 2,884,198 | |
| $66.54 | +5.23 | +8.5% | $62.30 | $67.05 | $61.70 | 2,857,908 | |
| $61.31 | +3.25 | +5.6% | $59.00 | $61.66 | $58.46 | 2,012,689 | |
| $58.06 | -5.73 | -9.0% | $61.94 | $62.33 | $57.86 | 3,262,133 | |
| $63.79 | +7.29 | +12.9% | $65.39 | $68.98 | $59.13 | 7,408,351 | |
| $56.50 | +0.81 | +1.5% | $57.07 | $59.38 | $55.80 | 4,339,422 | |
| $55.69 | -1.38 | -2.4% | $57.07 | $57.20 | $55.15 | 1,894,471 | |
| $57.07 | -4.93 | -8.0% | $59.47 | $60.17 | $56.00 | 1,921,320 | |
| $62.00 | 0.00 | 0.0% | $61.18 | $62.52 | $61.00 | 1,501,991 | |
| $62.00 | +1.26 | +2.1% | $60.66 | $63.39 | $60.55 | 2,981,331 | |
| $60.74 | +2.51 | +4.3% | $58.43 | $61.00 | $57.75 | 2,290,605 | |
| $58.23 | +0.64 | +1.1% | $57.79 | $58.30 | $57.28 | 2,329,686 | |
| $57.59 | +0.28 | +0.5% | $56.93 | $57.78 | $55.32 | 1,219,702 | |
| $57.31 | -1.795 | -3.0% | $59.11 | $60.67 | $55.52 | 2,371,664 | |
| $59.11 | +3.175 | +5.7% | $55.42 | $59.49 | $55.42 | 3,561,058 | |
| $55.93 | +0.56 | +1.0% | $55.52 | $56.94 | $54.85 | 1,567,468 | |
| $55.37 | +0.57 | +1.0% | $54.89 | $56.20 | $54.68 | 1,911,875 | |
| $54.80 | -1.74 | -3.1% | $56.45 | $57.18 | $54.27 | 1,674,200 | |
| $56.54 | +0.94 | +1.7% | $54.97 | $57.01 | $54.44 | 2,106,400 | |
| $55.60 | -0.59 | -1.1% | $55.39 | $58.08 | $54.57 | 2,335,500 | |
| $56.19 | -0.06 | -0.1% | $55.64 | $56.67 | $54.83 | 2,171,600 | |
| $56.25 | -2.59 | -4.4% | $58.75 | $58.75 | $55.89 | 1,863,000 | |
| $58.84 | +0.92 | +1.6% | $57.92 | $59.56 | $57.56 | 1,465,500 | |
| $57.92 | -1.80 | -3.0% | $59.23 | $59.23 | $56.29 | 2,556,000 | |
| $59.72 | -0.78 | -1.3% | $60.85 | $61.38 | $57.33 | 2,907,800 | |
| $60.50 | -3.36 | -5.3% | $64.67 | $66.42 | $59.30 | 2,903,800 | |
| $63.86 | +0.62 | +1.0% | $63.12 | $64.48 | $62.65 | 2,015,900 | |
| $63.24 | +1.30 | +2.1% | $62.25 | $64.36 | $62.25 | 2,227,600 | |
| $61.94 | -2.81 | -4.3% | $64.30 | $64.82 | $61.70 | 2,378,100 | |
| $64.75 | +0.24 | +0.4% | $64.32 | $66.98 | $63.86 | 2,138,900 | |
| $64.51 | +1.23 | +1.9% | $63.61 | $64.79 | $62.44 | 1,745,000 | |
| $63.28 | -0.90 | -1.4% | $63.22 | $64.95 | $62.37 | 2,612,700 | |
| $64.18 | +0.18 | +0.3% | $64.33 | $65.26 | $62.38 | 2,525,600 | |
| $64.00 | +4.33 | +7.3% | $59.17 | $65.00 | $59.17 | 2,256,900 | |
| $59.67 | -1.54 | -2.5% | $60.70 | $62.59 | $59.37 | 2,498,600 | |
| $61.21 | -0.37 | -0.6% | $62.29 | $62.47 | $60.91 | 1,981,500 | |
| $61.58 | +0.19 | +0.3% | $62.05 | $62.67 | $60.57 | 1,597,500 | |
| $61.39 | -1.66 | -2.6% | $63.37 | $63.49 | $60.40 | 2,820,300 | |
| $63.05 | +2.38 | +3.9% | $61.90 | $64.42 | $61.30 | 3,075,000 | |
| $60.67 | +4.92 | +8.8% | $56.64 | $61.72 | $56.61 | 4,105,800 | |
| $55.75 | +3.09 | +5.9% | $52.87 | $56.34 | $52.86 | 3,010,300 | |
| $52.66 | -0.77 | -1.4% | $53.11 | $53.62 | $51.54 | 2,784,900 | |
| $53.43 | -0.13 | -0.2% | $53.77 | $54.33 | $53.08 | 2,091,300 | |
| $53.56 | -0.87 | -1.6% | $53.21 | $54.31 | $52.58 | 1,882,900 | |
| $54.43 | -3.94 | -6.8% | $57.93 | $58.01 | $53.46 | 2,959,900 | |
| $58.37 | -0.13 | -0.2% | $57.58 | $58.57 | $56.80 | 1,040,700 | |
| $58.50 | -0.91 | -1.5% | $59.32 | $59.79 | $58.26 | 1,334,200 | |
| $59.41 | +0.39 | +0.7% | $59.82 | $60.29 | $57.47 | 1,208,600 | |
| $59.02 | +2.99 | +5.3% | $56.03 | $59.25 | $56.03 | 1,899,500 | |
| $56.03 | -1.98 | -3.4% | $57.79 | $58.00 | $55.66 | 2,028,200 | |
| $58.01 | +0.93 | +1.6% | $57.18 | $58.36 | $56.03 | 1,859,800 | |
| $57.08 | -2.17 | -3.7% | $58.68 | $59.21 | $56.85 | 1,928,400 | |
| $59.25 | +2.19 | +3.8% | $58.13 | $59.52 | $57.61 | 2,433,400 | |
| $57.06 | +0.21 | +0.4% | $56.26 | $57.56 | $56.26 | 2,528,300 | |
| $56.85 | -0.13 | -0.2% | $57.38 | $58.19 | $56.00 | 1,626,200 | |
| $56.98 | -2.58 | -4.3% | $59.01 | $59.11 | $56.90 | 1,174,200 | |
| $59.56 | -0.36 | -0.6% | $59.60 | $60.31 | $58.06 | 3,199,900 | |
| $59.92 | +1.27 | +2.2% | $57.07 | $61.41 | $57.07 | 1,414,800 |
- Ticker
- NASDAQ:BRKR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
Bruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of Directors
Latest earnings call · Nov 4, 2026
Bruker (NASDAQ:BRKR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Q3 2026 Earnings Presentation
Earnings · 17 slides
Latest news
Bruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of Directors
Nov 16, 2026
Closed $60.62 (-1.6%) on Nov 16, 2026
Bruker Reports Third Quarter 2026 Financial Results
Nov 4, 2026
Closed $63.79 (+12.9%) on Nov 4, 2026
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Oct 20, 2026
Closed $59.11 (+5.7%) on Oct 21, 2026
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
Oct 6, 2026
Closed $60.50 (-5.3%) on Oct 6, 2026
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
Sep 28, 2026
Closed $63.28 (-1.4%) on Sep 28, 2026
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
Sep 21, 2026
Closed $61.58 (+0.3%) on Sep 21, 2026
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
Sep 4, 2026
Closed $58.50 (-1.5%) on Sep 4, 2026
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
Aug 11, 2026
Closed $57.02 (+1.2%) on Aug 11, 2026
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
Aug 10, 2026
Closed $56.32 (+5.4%) on Aug 10, 2026
Bruker Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $50.30 (-21.8%) on Aug 4, 2026
Bruker Corporation on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 43 in the last 12 months · 271 in all · newest Nov 16, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Nov 4, 2026
- Decks
- 105 decks · latest Nov 4, 2026
Where Bruker Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BRKR · Home listing · This page | NASDAQ | United States | USD |
| NASDAQ:BRKRP | NASDAQ | United States | USD |
| gettex:BKD | gettex | Germany | EUR |
| Milan:1BRKR | Milan | Italy | EUR |
| BMV:BRKR | BMV | Mexico | MXN |
| LS Exchange:813534 | LS Exchange | Germany | EUR |
| B3:B2RK34 | B3 | Brazil | BRL |
| Lang & Schwarz:813534 | Lang & Schwarz | Germany | EUR |
| Tradegate:BKD | Tradegate | Germany | EUR |
| BOATS:BRKRP | BOATS | United States | USD |
| Frankfurt:BKD | Frankfurt | Germany | EUR |
| Dusseldorf:BKD | Dusseldorf | Germany | EUR |
| Hamburg:BKD | Hamburg | Germany | EUR |
| BIVA:BRKR | BIVA | Mexico | MXN |
| BOATS:BRKR | BOATS | United States | USD |
| Stuttgart:BKD | Stuttgart | Germany | EUR |
| BX Swiss:BKD | BX Swiss | Switzerland | CHF |
| Hanover:BKD | Hanover | Germany | EUR |
| Xetra:BKD | Xetra | Germany | EUR |
Valuation
EV/sales 2.9× against a median of 5.6×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $10.22B USD
- P/E
- Loss
- EV/sales
- 2.9×
- EV/EBITDA
- 64.4×
- Price/book
- 3.7×
- Gross margin
- 47.7%
- Operating margin
- −2.0%
- Net margin
- −3.5%
- Debt to equity
- 0.7×
- Beta vs S&P 500
- 1.72
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Qiagen N.V. · NYSE:QGEN | US$10.18B | US$11.03B | 24.9× | 5.3× | 15.0× | 3.0× | 19.5% | 0.5× | 0.33 |
| Avantor, Inc. · NYSE:AVTR | US$10.06B | US$13.28B | 29.8× | 2.0× | 14.7× | 1.7× | 5.1% | 0.6× | 0.78 |
| WuXi XDC Cayman, Inc. · HKEX:2268 | US$9.64B | US$8.87B | 43.5× | 10.0× | 33.5× | 5.7× | 24.9% | 0.1× | n/a |
| Tempus AI, Inc. · NASDAQ:TEM | US$9.58B | US$8.99B | n/a | 6.0× | n/a | 19.1× | −12.5% | 0.0× | 2.51 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.52B | US$8.23B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.51B | US$7.10B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Twist Bioscience Corporation · NASDAQ:TWST | US$7.04B | US$6.46B | n/a | 14.1× | n/a | 7.9× | −28.3% | 0.0× | 2.77 |
| Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821 | US$6.83B | US$5.89B | 38.5× | 5.3× | n/a | 2.6× | 15.9% | 0.0× | n/a |
| Median of the others | US$8.30B | US$7.87B | 29.8× | 5.6× | 22.8× | 3.2× | 13.5% | 0.1× | 0.78 |
Forecasts
5 strong buy · 1 buy · 6 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 68.00 USD · Analysts' mean
- EPS, year to Dec 2026
- 2.13 · 13 analysts
- Revenue, year to Dec 2026
- 3.54B · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Joe Kostka | Investor Relations |
| Kevin Cullen | VP, Innovation and Economic Development |
| Jason Serin | Manager of Lab Equipment Maintenance |
| Nawaf Algain | Manager of Tenant Affairs |
| Ohoud Alharbi | Executive Business Manager |
Board
| Director | Role |
|---|---|
| Stefan Lang | Director |
| Thierry Bernard | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Bruker (NASDAQ:BRKR) Q3 2026 Earnings Call | Wed, Nov 04, 2026 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 9:00 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q1 2026 Earnings Call | Wed, May 06, 2026 · 8:00 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q4 2025 Earnings Call | Thu, Feb 12, 2026 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q3 2025 Earnings Call | Mon, Nov 03, 2025 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q2 2025 Earnings Call | Mon, Aug 04, 2025 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q1 2025 Earnings Call | Wed, May 07, 2025 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q4 2024 Earnings Call | Thu, Feb 13, 2025 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q3 2024 Earnings Call | Tue, Nov 05, 2024 · 8:30 AM ET | Replay |
| Bruker (NASDAQ:BRKR) Q1 2024 Earnings Call | Thu, May 02, 2024 · 8:30 AM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 4, 2026 · Before open | +12.9% |
| Q2 2026 | Aug 4, 2026 · Before open | −21.8% |
| Q1 2026 | May 6, 2026 · Before open | +11.3% |
| Q4 2025 | Feb 12, 2026 · Before open | −11.6% |
| Q3 2025 | Nov 3, 2025 · Before open | −0.6% |
| Q2 2025 | Aug 4, 2025 · Before open | −8.6% |
| Q1 2025 | May 7, 2025 · Before open | +3.3% |
| Q4 2024 | Feb 13, 2025 · Before open | −1.0% |
| Q3 2024 | Nov 5, 2024 · Before open | +3.4% |
| Q2 2024 | Aug 6, 2024 · Before open | −2.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · Before open | −11.3% |
| Q4 2023 | Feb 13, 2024 · Before open | +8.8% |
| Q3 2023 | Nov 2, 2023 · Before open | −1.1% |
| Q2 2023 | Aug 3, 2023 · Before open | −4.8% |
| Q1 2023 | May 4, 2023 · Before open | +1.7% |
| Q4 2022 | Feb 9, 2023 · Before open | +1.3% |
| Q3 2022 | Nov 3, 2022 · Before open | +5.1% |
| Q2 2022 | Aug 3, 2022 · After close | −7.1% |
| Q1 2022 | May 4, 2022 · Before open | +6.3% |
| Q4 2021 | Feb 11, 2022 · Before open | −4.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 17 slides | Nov 4, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 17 slides | Aug 4, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 16 slides | May 6, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 17 slides | Feb 12, 2026 |
| J.P. Morgan 44th Annual Healthcare Conference 2026 | Conference | 22 slides | Jan 12, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 17 slides | Nov 3, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 17 slides | Aug 4, 2025 |
| Technical Presentation (June 2025) | Technical | 37 slides | Jun 26, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 23 slides | May 7, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 32 slides | Feb 13, 2025 |
Show 50 decks
This page holds 50 of 105 decks. Open Decks
Financings
| Raise | Date |
|---|---|
| Public offering of 6.375% Mandatory Convertible Preferred Stock, Series A Update: US$600M · J.P. Morgan +2 Dealers: J.P. Morgan (co-lead), BofA Securities (co-lead), PNC Capital Markets LLC Use of proceeds: Repay the term loan due December 2026 in full, revolving credit borrowings in full, and part of the term loan due March 2027 | Sep 3, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.44B | 3.37B | 2.96B | 2.53B | 2.42B | 1.99B | 2.07B | 1.90B | 1.77B | 1.61B |
| Cost of revenue | 1.86B | 1.72B | 1.45B | 1.23B | 1.21B | 1.05B | 1.08B | 995.6M | 949.9M | 866.0M |
| Gross profit | 1.58B | 1.65B | 1.51B | 1.31B | 1.21B | 939.8M | 995.3M | 900.0M | 816.0M | 745.3M |
| Research and development | 395.2M | 376.5M | 294.8M | 235.9M | 220.8M | 198.0M | 187.7M | 173.4M | 161.6M | 147.9M |
| Selling, general and administrative | 946.5M | 893.8M | 729.4M | 607.4M | 561.2M | 468.6M | 500.2M | 444.7M | 415.2M | 389.8M |
| Operating income | 68.2M | 253.1M | 436.9M | 432.7M | 413.3M | 248.3M | 300.9M | 262.4M | 219.5M | 181.8M |
| Depreciation and amortization | 220.3M | 183.8M | 114.9M | 88.8M | 89.1M | 80.4M | 75.6M | 64.9M | 63.9M | 54.3M |
| EBITDA | 288.5M | 436.9M | 551.8M | 521.5M | 502.4M | 328.7M | 376.5M | 327.3M | 283.4M | 236.1M |
| Interest expense | 60.3M | 47.9M | 16.4M | 16.1M | 14.3M | 14.4M | 16.0M | 12.6M | 15.4M | 13.2M |
| Income before tax | 22.0M | 206.9M | 544.2M | 413.9M | 393.6M | 225.8M | 280.4M | 244.7M | 197.8M | 177.6M |
| Income tax | 29.3M | 91.4M | 117.7M | 116.4M | 113.0M | 64.4M | 82.4M | 63.7M | 117.5M | 23.1M |
| Net income | -8.60M | 113.1M | 427.2M | 296.6M | 277.1M | 157.8M | 197.2M | 179.7M | 78.6M | 153.6M |
| Earnings per share, basic | -0.15 | 0.76 | 2.92 | 2.00 | 1.83 | 1.03 | 1.27 | 1.15 | 0.50 | 0.95 |
| Earnings per share, diluted | -0.15 | 0.76 | 2.90 | 1.99 | 1.81 | 1.02 | 1.26 | 1.14 | 0.49 | 0.95 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 298.8M | 183.4M | 488.3M | 645.5M | 1.07B | 681.8M | 678.3M | 322.4M | 325.0M | 342.4M |
| Short-term investments | 12.0M | 0 | 100.0M | 50.0M | 6.60M | 0 | 114.2M | 157.9M | ||
| Receivables | 544.9M | 565.5M | 492.0M | 472.7M | 416.9M | 335.3M | 362.2M | 357.2M | 319.3M | 243.9M |
| Inventory | 1.09B | 1.07B | 968.3M | 800.1M | 710.1M | 692.3M | 577.2M | 509.6M | 486.2M | 440.4M |
| Current assets | 2.21B | 2.05B | 2.16B | 2.11B | 2.47B | 1.93B | 1.80B | 1.30B | 1.36B | 1.28B |
| Property, plant and equipment | 744.8M | 669.3M | 599.7M | 487.0M | 406.1M | 395.5M | 306.1M | 270.6M | 266.5M | 239.1M |
| Goodwill | 1.55B | 1.51B | 582.6M | 457.6M | 339.5M | 320.4M | 293.0M | 275.7M | 169.8M | 130.6M |
| Total assets | 6.24B | 5.81B | 4.25B | 3.61B | 3.65B | 3.05B | 2.77B | 2.13B | 1.95B | 1.81B |
| Accounts payable | 215.9M | 234.1M | 202.7M | 178.4M | 147.4M | 134.6M | 118.4M | 104.5M | 90.8M | 86.1M |
| Current liabilities | 1.28B | 1.28B | 1.20B | 914.3M | 938.5M | 791.9M | 645.6M | 599.3M | 524.5M | 524.7M |
| Long-term debt | 1.85B | 2.06B | 1.16B | 1.20B | 1.22B | 842.3M | 812.8M | 322.6M | 415.6M | 391.6M |
| Total debt | 1.87B | 2.09B | 1.28B | 1.22B | 1.33B | 844.5M | 813.3M | 341.1M | 415.6M | 411.7M |
| Total liabilities | 3.73B | 3.99B | 2.84B | 2.48B | 2.57B | 2.07B | 1.83B | 1.22B | 1.22B | 1.12B |
| Shareholders' equity | 2.46B | 1.78B | 1.38B | 1.11B | 1.07B | 961.2M | 906.8M | 896.6M | 725.4M | 686.4M |
| Shares outstanding | 152.1M | 151.7M | 145.2M | 147.0M | 150.8M | 152.0M | 154.2M | 156.6M | 155.9M | 159.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 134.1M | 251.3M | 350.1M | 274.4M | 282.4M | 332.2M | 213.4M | 239.7M | 154.4M | 130.8M |
| Capital spending | -90.8M | -115.3M | -106.9M | -129.2M | -92.0M | -97.2M | -73.0M | -49.2M | -43.7M | -37.1M |
| Free cash flow | 43.3M | 136.0M | 243.2M | 145.2M | 190.4M | 235.0M | 140.4M | 190.5M | 110.7M | 93.7M |
| Cash from investing | -196.5M | -1.76B | -326.0M | -251.6M | -192.4M | -192.7M | -158.4M | -123.4M | -30.2M | -21.8M |
| Cash from financing | 135.1M | 1.23B | -193.4M | -415.3M | 318.7M | -161.6M | 300.0M | -112.4M | -159.0M | -27.9M |
| Dividends paid | -22.8M | -30.2M | -29.4M | -29.8M | -24.2M | -24.6M | -25.0M | -25.1M | -25.4M | -25.8M |
| Share buybacks | -10.0M | 0 | -152.3M | -263.1M | -153.3M | -123.2M | -142.3M | -152.2M | -152.2M | -160.0M |
| Change in cash | 116.4M | -304.9M | -157.1M | -423.0M | 386.2M | 3.60M | 355.6M | -2.60M | -17.0M | 74.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 16, 2026 | Management or board change | SEC |
| 8-K · Current report | Nov 5, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 8-K · Current report | Oct 29, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 14, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 14, 2026 | Current report | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 6, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 8-K · Current report | Jul 30, 2026 | Current report | SEC |
| 4 · Change in ownership | Jul 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 15, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Jul 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 15, 2026 | Other filings | SEC |
| S-3ASR · Registration statement | Jun 12, 2026 | Offer document | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K/A · Current report, amended | May 29, 2026 | Meeting outcome | SEC |
| 8-K · Current report | May 21, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 8-K · Current report | May 15, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | May 15, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| 8-K · Current report | Apr 28, 2026 | Current report | SEC |
| 4 · Change in ownership | Apr 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 15, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 10, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 10, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 10, 2026 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Apr 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 10, 2026 | Management or board change | SEC |
| 8-K · Current report | Apr 1, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 13, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 6, 2026 | Big-stake notice | SEC |
| S-8 POS | Feb 27, 2026 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Feb 27, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 20, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 13, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 12, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 12, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Jan 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 5, 2026 | Other filings | SEC |
| 8-K · Current report | Dec 9, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 3, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 7, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 12, 2025 | Other filings | SEC |
| CERT · Exchange's certificate of listing | Sep 8, 2025 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Sep 8, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 8, 2025 | Current report | SEC |
| 424B5 · Prospectus | Sep 5, 2025 | Offer document | SEC |
| FWP · Free writing prospectus | Sep 4, 2025 | Offer document | SEC |
| 424B5 · Prospectus | Sep 2, 2025 | Offer document | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 6, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2025 | Results | SEC |
| 8-K · Current report | Jul 21, 2025 | Results | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 8-K · Current report | May 29, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| DEFA14A · Additional proxy material | May 19, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 8-K · Current report | May 14, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 12, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 24, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 11, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 11, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 11, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 11, 2025 | Results | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 3, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 21, 2025 | Management or board change | SEC |
| 3 · Initial statement of ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 13, 2025 | Results | SEC |
| 3 · Initial statement of ownership | Jan 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2025 | Management or board change | SEC |
| 8-K · Current report | Jan 13, 2025 | Results | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 2, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2024 | Results | SEC |
| 4 · Change in ownership | Aug 16, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 15, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 7, 2024 | Management or board change | SEC |
| 8-K · Current report | Aug 6, 2024 | Results | SEC |
| 8-K/A · Current report, amended | Jun 5, 2024 | Material contract | SEC |
| 8-K · Current report | May 31, 2024 | Material contract | SEC |
| 424B5 · Prospectus | May 30, 2024 | Offer document | SEC |
| 8-K · Current report | May 30, 2024 | Meeting outcome | SEC |
| S-3ASR · Registration statement | May 29, 2024 | Offer document | SEC |
| SD · Specialized disclosure | May 23, 2024 | ESG report | SEC |
| ARS · Annual report to shareholders | May 15, 2024 | Annual report | SEC |
| 10-Q · Quarterly report | May 10, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2024 | Results | SEC |
| 8-K · Current report | May 2, 2024 | Current report | SEC |
| 8-K · Current report | Apr 22, 2024 | Material contract | SEC |
| DEFA14A · Additional proxy material | Apr 19, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 19, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 2, 2024 | Material contract | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 4, 2024 | Other filings | SEC |
| 4 · Change in ownership | Mar 1, 2024 | Insider trade | SEC |
| 10-K · Annual report | Feb 29, 2024 | Annual report | SEC |
| 144 · Notice of proposed sale | Feb 28, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 26, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 22, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Bruker Corporation’s releases
- Common shares
- 152,722,385
- Fully diluted
- 152,722,385
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 152,722,385 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 152,722,385 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Laura Francis Other companies: SI-BONE, Inc. (Chief Executive Officer · Since at least Oct 16, 2018); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past) | Director · Since at least Feb 18, 2025 |
| Bonnie H Anderson Other companies: Veracyte, Inc. (Director · May 1, 2022 – Jun 2, 2023 · Past) | Director · Since at least Jan 5, 2023 |
| Jack Phillips Other companies: Accelerate Diagnostics Inc (Chief Executive Officer, Director · Aug 6, 2019 – Apr 4, 2025 · Past) | Director · Since at least Jan 1, 2026 |
| Joe Kostka Other companies: SI-BONE, Inc. (Director, Investor Relations · Feb 21, 2025 – Nov 4, 2026 · Past) | Investor Relations · Since at least Dec 10, 2025 |
| John A Ornell Other companies: Waters Corporation (CFO · Aug 6, 2010 – Dec 6, 2013 · Past) | Director · Since at least Aug 19, 2015 |
| Richard A Packer Other companies: Teleflex Incorporated (Director · May 7, 2019 – May 4, 2021 · Past) | Director · Since at least Dec 16, 2019 |
| Thomas Bures Other companies: Palvella Therapeutics, Inc. (Chief Financial Officer · Sep 3, 2019 – Feb 24, 2023 · Past) | Chief Accounting Officer · Since at least Jan 13, 2025 |
| Adelene Q Perkins | Director · Since at least Jan 5, 2024 |
| Burkhard Prause | PRES. & CEO, BRUKER BEST · Since at least Mar 7, 2012 |
| Frank H Laukien | PRESIDENT & CEO, Director · Since at least Oct 26, 2023 |
All 26 people
| Person | Seat |
|---|---|
| Gerald N Herman | EXECUTIVE VICE PRESIDENT, CFO · Since at least Aug 11, 2022 |
| Hermann Fritz Requardt | Director · Since at least Feb 15, 2026 |
| Jason Serin | Manager of Lab Equipment Maintenance · Since at least Nov 4, 2026 |
| Juergen Srega | PRESIDENT CALID · Since at least Aug 5, 2021 |
| Kevin Cullen | VP, Innovation and Economic Development · Since at least Nov 4, 2026 |
| Marc A Kastner | Director · Feb 12, 2013 – May 19, 2023 · Past |
| Mark Munch | EXEC VP&PRES BRUKER NANO INC. · Since at least Aug 5, 2022 |
| Nawaf Algain | Manager of Tenant Affairs · Since at least Nov 4, 2026 |
| Ohoud Alharbi | Executive Business Manager · Since at least Nov 4, 2026 |
| Richard Kniss | Director · Jan 5, 2017 – Jan 5, 2018 · Past |
| Stefan Lang | Director · Since at least Jan 9, 2026 |
| Stephan Westermann | EVP-OEP&L · Mar 7, 2012 – Mar 7, 2012 · Past |
| Thierry Bernard | Director · Since at least Apr 1, 2026 |
| William A Linton | Director · Since at least Jan 5, 2011 |
| Wolf-Dieter Emmerich | Director · Jan 5, 2011 – May 12, 2016 · Past |
| Wolfgang Pusch | President BMID Group · Since at least Jul 1, 2026 |
Log in to ask 6ix AI your own questions about Bruker Corporation.